HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MicroRNA-182-5p Attenuates Asthmatic Airway Inflammation by Targeting NOX4.

Abstract
Bronchial asthma is characterized by chronic airway inflammation, airway hyperresponsiveness, and airway remodeling. MicroRNA (miRNA) has recently been implicated in the pathogenesis of asthma. However, the mechanisms of different miRNAs in asthma are complicated, and the mechanism of miRNA-182-5p in asthma is still unclear. Here, we aim to explore the mechanism of miRNA182-5p in asthma-related airway inflammation. Ovalbumin (OVA)-induced asthma model was established. MiRNA Microarray Analysis was performed to analyze the differentially expressed miRNAs in the asthma model. We found that the expression of miRNA-182-5p was significantly decreased in OVA-induced asthma. In vitro, IL-13 stimulation of BEAS-2B cells resulted in a significant up-regulation of NOX4 (nicotinamide adenine dinucleotide phosphate oxidase 4), accompanied by mitochondrial damage-induced apoptosis, NLRP3 (NOD-like receptor family pyrin domain-containing 3)/IL-1β activation, and reduced miRNA-182-5p. In contrast, overexpression of miRNA-182-5p significantly inhibited epithelial cell apoptosis and NLRP3/IL-1β activation. In addition, we found that miRNA-182-5p could bind to the 3' untranscripted region of NOX4 mRNA and inhibit epithelial cell inflammation by reducing oxidative stress and mitochondrial damage. In vivo, miRNA-182-5p agomir treatment significantly reduced the percentage of eosinophils in bronchoalveolar lavage fluid, and down-regulated Th2 inflammatory factors, including IL-4, IL-5, and OVA induced IL-13. Meanwhile, miRNA-182-5p agomir reduced the peribronchial inflammatory cell infiltration, goblet cell proliferation and collagen deposition. In summary, targeting miRNA-182-5p may provide a new strategy for the treatment of asthma.
AuthorsZhiguang Wang, Yilan Song, Jingzhi Jiang, Yihua Piao, Li Li, Qiaoyun Bai, Chang Xu, Hanye Liu, Liangchang Li, Hongmei Piao, Guanghai Yan
JournalFrontiers in immunology (Front Immunol) Vol. 13 Pg. 853848 ( 2022) ISSN: 1664-3224 [Electronic] Switzerland
PMID35711428 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2022 Wang, Song, Jiang, Piao, Li, Bai, Xu, Liu, Li, Piao and Yan.
Chemical References
  • Interleukin-13
  • MicroRNAs
  • Mirn182 microRNA, mouse
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Ovalbumin
  • NADPH Oxidase 4
  • Nox4 protein, mouse
Topics
  • Animals
  • Asthma (metabolism)
  • Inflammation (genetics, metabolism)
  • Interleukin-13 (genetics)
  • Mice
  • Mice, Inbred BALB C
  • MicroRNAs (genetics)
  • NADPH Oxidase 4 (genetics)
  • NLR Family, Pyrin Domain-Containing 3 Protein (genetics)
  • Ovalbumin (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: